Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
Dae Sik Kim, Yoo Jin Na, Myoung Hee Kang, Soo-Young Yoon, Chul Won Choi
Korean J Intern Med. 2016;31(2):357-366.   Published online 2016 Feb 15     DOI: https://doi.org/10.3904/kjim.2015.024
Citations to this article as recorded by Crossref logo
IL33andIL1RL1variants are associated with asthma and atopy in a Brazilian population
G. A. Queiroz, R. S. Costa, N. M. Alcantara-Neves, G. Nunes de Oliveira Costa, M. L. Barreto, V. L. Carneiro, C. A. Figueiredo
International Journal of Immunogenetics.2017; 44(2): 51.     CrossRef
MPT0B002, a novel microtubule inhibitor, downregulates T315I mutant Bcr-Abl and induces apoptosis of imatinib-resistant chronic myeloid leukemia cells
Yi-Yen Yeh, Jing-Ping Liou, Yueh-Lun Lee, John Yi-Chung Lin, Huei-Mei Huang
Investigational New Drugs.2017; 35(4): 427.     CrossRef
Iron metabolism and drug resistance in cancer
Hasan Huseyin Kazan, Cagri Urfali-Mamatoglu, Ufuk Gunduz
BioMetals.2017; 30(5): 629.     CrossRef